Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 13, Number 10—October 2007

Research

Personal Protective Equipment and Antiviral Drug Use during Hospitalization for Suspected Avian or Pandemic Influenza1

Ashwin Swaminathan*, Rhea Martin*, Sandi Gamon*, Craig Aboltins†, Eugene Athan‡, George Braitberg*, Michael G. Catton§, Louise Cooley¶, Dominic E. Dwyer#, Deidre Edmonds*, Damon P. Eisen**, Kelly Hosking*, Andrew J. Hughes‡, Paul D. Johnson*††, Andrew V Maclean‡‡, Mary O’Reilly‡‡, S. Erica Peters§§, Rhonda L. Stuart¶¶, Rodney Moran##, and M. Lindsay Grayson*††***Comments to Author 
Author affiliations: *Austin Health, Melbourne, Victoria, Australia; †St. Vincent’s Health, Melbourne, Victoria, Australia; ‡Barwon Health, Geelong, Victoria, Australia; §Victorian Infectious Diseases Reference Laboratory, Melbourne, Victoria, Australia; ¶Royal Hobart Hospital, Hobart, Tasmania, Australia; #Westmead Hospital, Sydney, New South Wales, Australia; **Royal Melbourne Hospital, Melbourne, Victoria, Australia; ††University of Melbourne, Melbourne, Victoria, Australia; ‡‡Box Hill Hospital–Eastern Health, Melbourne, Victoria, Australia; §§Western Hospital, Melbourne, Victoria, Australia; ¶¶Monash Medical Centre–Southern Health, Melbourne, Victoria, Australia; ##Department of Human Services, Melbourne, Victoria, Australia; ***Monash University, Melbourne, Victoria, Australia;

Main Article

Table 3

Number of close contacts (CCs) and exposures to API patient*

Characteristic
No. CCs (no. exposures) per hospital
A
B
C
D
E
F
G
H
I
Mean
Total 17 (26) 15 (20) 6 (15) 11 (20) 14 (17) 12 (20) 11 (17) 10 (11)† 6 (8)† 12.3 (19.3)‡
By clinical area
Triage 8 (8) 4 (4) 1 (1) 2 (2) 5 (5) 1 (1) 3 (3) 7 (7) 3 (3) 3.8 
(3.8)
ED 5 (11) 7 (11) 3 (9) 7 (10) 6 (9) 7 (10) 6 (9) 3 (4)† 3 (5)† 5.9 (9.9)‡
Ward
4 (7)
4 (5)
2 (5)
2 (8)
3 (3)
4 (9)
2 (5)


3.0 
(6.0)
By study period, h
0–1 10 (12) 8 (8) 3 (4) 6 (8) 7 (7) 8 (8) 5 (5) 9 (10) 5 (6) 6.8 
(7.6)
1–2 2 (3) 0 (1) 1 (2) 2 (2) 3 (5) 2 (6) 3 (3) 0 (0) 1 (2) 1.6 
(2.7)
2–3 2 (4) 0 (2) 0 (4) 3 (5) 2 (3) 1 (3) 0 (2) 1 (1)† 0 (0)† 1.1 (3.3)‡
3–4 3 (5) 5 (6) 2 (3) 0 (2) 0 (0) 1 (1) 2 (3) 1.9 
(2.9)
4–5 0 (1) 2 (2) 0 (1) 0 (1) 1 (1) 0 (2) 1 (2) 0.6 
(1.4)
5–6
0 (0)
0 (1)
0 (1)
0 (2)
1 (1)
0 (0)
0 (2)


0.1 
(1.0)
By HCW status
Non-HCW 3 (3) 5 (5) 0 (0) 0 (0) 3 (3) 0 (0) 2 (2) 4 (4)† 0 (0)† 1.9 (1.9)‡
HCW
14 (23)
10 (15)
6 (15)
11 (20)
11 (14)
12 (20)
9 (15)
6 (7)†
6 (8)†
10.4 (17.4)‡
No. HCW CCs (%) who wore complete PPE set during each exposure§
2
3
5
9
8
8
8
2†
3†
6.1 
(59)‡
No. HCW CCs (%) who wore N95 masks during each exposure§ 12 7 6 10 11 12 9 5† 3† 9.6 
(92)‡

*API, avian (H5N1) or pandemic influenza; ED, emergency department; HCW, healthcare worker; PPE, personal protective equipment.
†Incomplete data as simulation terminated after 2.5 h.
‡Excludes data from sites H and I.
§World Health Organization recommendations (Table 1).

Main Article

1This research was presented in part at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, USA, September 17-20, 2007.

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO